Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

07/08/2025 07:37

Aug 7 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             65.15               62.57           280.00    
                 (+4.1 pct)          (+14.7 pct)      (+7.9 pct)  
  Operating          5.21                5.67            27.00    
                 (-8.2 pct)          (+38.5 pct)      (+16.2 pct) 
  Recurring          3.95                8.59            25.30    
                 (-54.0 pct)         (+23.5 pct)      (-3.3 pct)  
  Net                2.51                5.50            17.70    
                 (-54.3 pct)         (+15.7 pct)      (-6.8 pct)  
  EPS             51.06 yen          111.64 yen       359.57 yen  
  Ann Div                             70.00 yen        80.00 yen  
  -Q2 div                             30.00 yen        40.00 yen  
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T